Pharmacokinetics of intravenous fluticasone propionate in healthy subjects.

@article{Mackie1996PharmacokineticsOI,
  title={Pharmacokinetics of intravenous fluticasone propionate in healthy subjects.},
  author={Alan Mackie and G. P. Ventresca and Richard W Fuller and A. R. Bye},
  journal={British journal of clinical pharmacology},
  year={1996},
  volume={41 6},
  pages={
          539-42
        }
}
1. Fluticasone propionate (FP) is a potent glucocorticoid used in the treatment of asthma. Prior to reporting the pharmacokinetics following the inhaled and oral routes, the pharmacokinetics need to be established following intravenous dosing. The present study determines the intravenous pharmacokinetics of FP, using non-compartmental analysis, in healthy male subjects over the 250 to 1000 micrograms dose range. 2. The pharmacokinetics of FP can be regarded as being linear over this dosing… CONTINUE READING
Highly Cited
This paper has 26 citations. REVIEW CITATIONS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

Development of a novel model for comparative evaluation of intranasal pharmacokinetics and effects of anti-allergic nasal sprays.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V • 2012